Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | Mar' 22 | |
|---|---|---|---|---|---|
| Sales | 356.14 | 358.14 | 374.27 | 1,136.98 | 364.70 |
| Operating profit | 73.81 | 76.74 | 76.79 | 231.54 | 68.21 |
| Interest | 3.82 | 4.03 | 5.80 | 14.69 | 4.40 |
| Gross profit | 69.99 | 77.57 | 70.99 | 218.13 | 66.32 |
| EPS (Rs) | 4.61 | 5.26 | 4.41 | 14.54 | 897.60 |
Quarterly
results in details
| Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | Mar' 22 | |
|---|---|---|---|---|---|
| Other income | - | 4.86 | - | 1.28 | 2.51 |
| Stock adjustment | -6.11 | -19.29 | -8.70 | -82.53 | 3.02 |
| Raw material | 196.88 | 193.64 | 210.12 | 689.33 | 206.02 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 29.84 | 31.53 | 30.94 | 91.22 | 29.29 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 61.72 | 75.52 | 65.12 | 207.42 | 58.16 |
| Provisions made | - | - | - | - | - |
| Depreciation | 16.32 | 15.44 | 14.25 | 41.52 | 12.44 |
| Taxation | 11.86 | 14.50 | 16.75 | 44.88 | 9.00 |
| Net profit / loss | 41.81 | 47.63 | 39.99 | 131.73 | 44.88 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 45.31 | 45.31 | 45.31 | 45.31 | 0.25 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 20.72 | 21.43 | 20.52 | 20.36 | 18.70 |
| GPM (%) | - | 21.37 | - | 19.16 | 18.06 |
| NPM (%) | - | 13.12 | - | 11.57 | 12.22 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis